Market Cap 235.68M
Revenue (ttm) 440,000.00
Net Income (ttm) -35.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -7,984.09%
Debt to Equity Ratio 0.00
Volume 516,800
Avg Vol 357,210
Day's Range N/A - N/A
Shares Out 13.15M
Stochastic %K 70%
Beta 0.93
Analysts Strong Sell
Price Target $33.67

Company Profile

Avalo Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States. Its lead asset includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and i...

Industry: Biotechnology
Sector: Healthcare
Phone: 410 522 8707
Address:
540 Gaither Road, Suite 400, Rockville, United States
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 2:28 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $AVTX Current Share Price: $17.76 Contracts: $AVTX May 15, 2026 $20 Calls Scale in: $5.11- $6.24 Scale out: $7.94-$10.21 Can Easily Capture: 60% ROI Blended DTE: 204 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
Toffeepanda
Toffeepanda Oct. 24 at 10:14 PM
0 · Reply
Trapjaw
Trapjaw Oct. 24 at 12:02 PM
$AVTX 🤣 ok i take it 29 %
0 · Reply
Trapjaw
Trapjaw Oct. 24 at 11:31 AM
$AVTX Cantor #Biotechnology: Today @ 2 PM ET - Panel Discussion with Leading Dermatologists $AVTX $PTGX
0 · Reply
sccp1910
sccp1910 Oct. 24 at 10:49 AM
0 · Reply
Trapjaw
Trapjaw Oct. 24 at 10:15 AM
0 · Reply
Trapjaw
Trapjaw Oct. 23 at 8:01 PM
0 · Reply
WallGoodman
WallGoodman Oct. 23 at 2:28 PM
$AVTX your welcome..
0 · Reply
Trapjaw
Trapjaw Oct. 23 at 2:26 PM
$AVTX i remember the days wen vol was 3k a day🤣
0 · Reply
Trapjaw
Trapjaw Oct. 23 at 2:22 PM
$AVTX why is this not tren ding 🤣
0 · Reply
Latest News on AVTX
Avalo Therapeutics Appoints Kevin R. Lind to Board of Directors

Sep 22, 2025, 7:00 AM EDT - 4 weeks ago

Avalo Therapeutics Appoints Kevin R. Lind to Board of Directors


Avalo Reports 2024 Financial Results and Recent Business Updates

Mar 20, 2025, 7:00 AM EDT - 7 months ago

Avalo Reports 2024 Financial Results and Recent Business Updates


Avalo Therapeutics Announces 1-for-240 Reverse Stock Split

Dec 27, 2023, 7:00 AM EST - 1 year ago

Avalo Therapeutics Announces 1-for-240 Reverse Stock Split


Avalo Completes Divestiture of AVTX-800 Series

Oct 31, 2023, 7:00 AM EDT - 2 years ago

Avalo Completes Divestiture of AVTX-800 Series


Top trending biotech stocks: ANVS, MTNB, AVTX, TPST

Oct 12, 2023, 11:26 AM EDT - 2 years ago

Top trending biotech stocks: ANVS, MTNB, AVTX, TPST

ANVS MTNB TPST


Avalo Enters into Agreement to Divest AVTX-800 Series

Sep 12, 2023, 7:00 AM EDT - 2 years ago

Avalo Enters into Agreement to Divest AVTX-800 Series


Avalo to Participate in SVB Securities Therapeutics Forum

Jul 6, 2023, 4:01 PM EDT - 2 years ago

Avalo to Participate in SVB Securities Therapeutics Forum


Avalo to Present at the Jefferies Healthcare Conference

Jun 1, 2023, 7:00 AM EDT - 2 years ago

Avalo to Present at the Jefferies Healthcare Conference


Avalo to Present at ATS 2023 Respiratory Innovation Summit

May 15, 2023, 7:00 AM EDT - 2 years ago

Avalo to Present at ATS 2023 Respiratory Innovation Summit


LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 2:28 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $AVTX Current Share Price: $17.76 Contracts: $AVTX May 15, 2026 $20 Calls Scale in: $5.11- $6.24 Scale out: $7.94-$10.21 Can Easily Capture: 60% ROI Blended DTE: 204 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
Toffeepanda
Toffeepanda Oct. 24 at 10:14 PM
0 · Reply
Trapjaw
Trapjaw Oct. 24 at 12:02 PM
$AVTX 🤣 ok i take it 29 %
0 · Reply
Trapjaw
Trapjaw Oct. 24 at 11:31 AM
$AVTX Cantor #Biotechnology: Today @ 2 PM ET - Panel Discussion with Leading Dermatologists $AVTX $PTGX
0 · Reply
sccp1910
sccp1910 Oct. 24 at 10:49 AM
0 · Reply
Trapjaw
Trapjaw Oct. 24 at 10:15 AM
0 · Reply
Trapjaw
Trapjaw Oct. 23 at 8:01 PM
0 · Reply
WallGoodman
WallGoodman Oct. 23 at 2:28 PM
$AVTX your welcome..
0 · Reply
Trapjaw
Trapjaw Oct. 23 at 2:26 PM
$AVTX i remember the days wen vol was 3k a day🤣
0 · Reply
Trapjaw
Trapjaw Oct. 23 at 2:22 PM
$AVTX why is this not tren ding 🤣
0 · Reply
Trapjaw
Trapjaw Oct. 23 at 2:18 PM
0 · Reply
Trapjaw
Trapjaw Oct. 23 at 1:45 PM
0 · Reply
CaptainCoin3
CaptainCoin3 Oct. 23 at 1:41 PM
$AVTX TO THE MOOOOON!!!
0 · Reply
Trapjaw
Trapjaw Oct. 23 at 11:20 AM
0 · Reply
ret0258
ret0258 Oct. 23 at 11:17 AM
$AVTX 20+
0 · Reply
Trapjaw
Trapjaw Oct. 23 at 10:47 AM
0 · Reply
Trapjaw
Trapjaw Oct. 23 at 10:30 AM
0 · Reply
Trapjaw
Trapjaw Oct. 22 at 1:59 PM
0 · Reply
mikesterz7
mikesterz7 Oct. 22 at 11:37 AM
$AVTX Analysts at H.C. Wainwright, Oppenheimer, TD Cowen, and Cantor Fitzgerald maintain bullish views on Avalo, with price targets ranging from $25 to $35 and expectations that AVTX-009 could outperform AbbVie’s rival therapy.
1 · Reply
Trapjaw
Trapjaw Oct. 22 at 9:48 AM
0 · Reply
DrevanTheStillblade
DrevanTheStillblade Oct. 22 at 8:51 AM
GIPR has optionality baked in. Real estate gives downside protection. A story shift (tokenization of assets, digital‑asset holdings, lease re‑ratings) gives upside. At current levels, the range up to $10+, even $13+, starts feeling very plausible when the market recognizes it. $VCIG $AVTX $YOSH $KPRX
0 · Reply
StocktwitsNews
StocktwitsNews Oct. 22 at 8:12 AM
Avalo Therapeutics Stock Rises Premarket Ahead Of Oppenheimer Call On Lead Hidradenitis Drug $AVTX https://stocktwits.com/news/equity/markets/avalo-therapeutics-stock-rises-premarket-ahead-of-oppenheimer-call-on-lead-hidradenitis-drug/cLG5chVR3pw
1 · Reply